Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study

AIM: Previously, we reported on the efficacy and safety of guanfacine extended‐release (GXR) in Japanese adults with attention‐deficit/hyperactivity disorder (ADHD) from a phase 3, double‐blind, placebo‐controlled, randomized trial. In this exploratory post hoc analysis, we assessed the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Naya, Noriyuki, Sakai, Chika, Okutsu, Daiki, Kiguchi, Ryo, Fujiwara, Masakazu, Tsuji, Toshinaga, Iwanami, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182954/
https://www.ncbi.nlm.nih.gov/pubmed/33305542
http://dx.doi.org/10.1002/npr2.12152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182954/
https://www.ncbi.nlm.nih.gov/pubmed/33305542
http://dx.doi.org/10.1002/npr2.12152

Ejemplares similares